Citrullination of NF‐κB p65 by PAD2 as a Novel Therapeutic Target for Modulating Macrophage Polarization in Acute Lung Injury (Adv. Sci. 18/2025)
Source abstract
Abstract
Therapy for PA-Induced Acute Lung Injury In article number 2413253, Xin Yu, Yujing Song, Katsuo Kurabayashi, Yongqing Li, and co-workers discover a new chemical modification site catalyzed by an enzyme called PAD2 on the intracellular protein, NF-κB p65, which modulates immune cell (macrophage) functions. Using nanoparticle therapy to block PAD2 significantly reduced inflammation and improved outcomes in acute lung injury during bacterial infections.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Microbial Applications in Construction Materials · Inflammation biomarkers and pathways · Cancer Research and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References
Reference metadata was not supplied for this record.